Composition and method for spray drying an adjuvant vaccine emulsion
AU2018330165A1
Liposomal formulations comprising saponin and methods of use
US2020230056A1
Nanostructured lipid carriers and stable emulsions and uses thereof
CN111315362A
Nanostructured lipid carriers and stable emulsions and uses thereof
MX2019003035A
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy.
EP3458088A2
Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium infections
US2020085757A1
Nanoalum Particles Containing a Sizing Agent
CN109562057A
Pegylated liposomal and application method
MX2018014086A
Formulation containing tlr agonist and methods of use.
CA2935620A1
Single vial vaccine formulations
US2015087615A1
Compositions and methods for reducing or preventing metastasis
BR112015024860A2
vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
BR112015024877A2
vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
AU2013224764A1
Vaccine composition containing synthetic adjuvant
BR112015002483A2
compositions and methods for treating an active infection with mycobacterium tuberculosis
CN104363892A
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
WO2012064659A1
Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
WO2012057904A1
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity
CN102083853A
Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
